Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Day One Biopharmaceuticals (DAWN) Asset Utilization Ratio: 2025

Historic Asset Utilization Ratio for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Sep 2025 value amounting to 0.26.

  • Day One Biopharmaceuticals' Asset Utilization Ratio was N/A to 0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26, marking a year-over-year change of. This contributed to the annual value of 0.27 for FY2024, which is N/A change from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.26 for Q3 2025, which was down 27.34% from 0.36 recorded in Q2 2025.
  • Over the past 5 years, Day One Biopharmaceuticals' Asset Utilization Ratio peaked at 0.36 during Q2 2025, and registered a low of 0.26 during Q3 2025.
  • In the last 1 years, Day One Biopharmaceuticals' Asset Utilization Ratio had a median value of 0.29 in 2025 and averaged 0.30.